Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Langmuir ; 38(47): 14439-14450, 2022 Nov 29.
Artículo en Inglés | MEDLINE | ID: mdl-36378533

RESUMEN

A four-stage oscillating feedback millireactor with splitters (S-OFM) was designed to improve the mixing performance based on chaotic advection. Three-dimensional CFD simulations were used to investigate its flow characteristics and mixing performance, and the generation mechanisms of secondary flows were examined. The results show that the mixing index (MIcup) increased with the increase in the Reynolds number (Re), and MIcup could reach 99.8% at Re = 663. Poincaré mapping and Kolmogorov entropy were adopted to characterize the chaotic advection intensity, which indicates that there is a intensity increase with the increase in Re. In addition, the results of Villermaux-Dushman experiments demonstrate that S-OFM performs excellently, and the mixing time could reach 1.04 ms at Re = 2764. Finally, S-OFM was successfully used to synthesize CdS nanoparticles with cubic hexagonal phase junctions. At a flow rate of 180 mL/min, the average particle size was 10.5 nm and the particle size distribution was narrow (with a coefficient of variation of 0.14).

2.
Chem Biol Interact ; 398: 111112, 2024 Aug 01.
Artículo en Inglés | MEDLINE | ID: mdl-38901789

RESUMEN

Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS): Life-threatening medical conditions characterized by high morbidity and mortality rates, where the inflammatory process plays a crucial role in lung tissue damage, especially in models induced by lipopolysaccharide (LPS). Heat shock protein A12B (HSPA12B) has strong anti-infammatory properties However, it is unknown whether increased HSPA12B is protective against LPS-induced ALI. And Dexmedetomidine (DEX) is a potent α2-adrenergic receptor (α2-AR) agonist that has been shown to protect against sepsis-induced lung injury, however, the underlying mechanisms of this protection are not fully understood. This study utilized bioinformatics analysis and an LPS-induced ALI model to explore how DEX alleviates lung injury by modulating HSPA12B and inhibiting the Toll-like receptor 4/nuclear factor-kappa B (TLR4/NF-κB) signaling pathway. Results indicate that HSPA12B overexpression and DEX pre-treatment markedly mitigated LPS-induced lung injury, which was evaluated by the deterioration of histopathology, histologic scores, the W/D weight ratio, and total protein expression, tumor necrosis factor-alpha (TNF-α), and interleukin-1ß (IL-1ß) in the BALF, and the levels of NO, MDA,SOD and MPO in the lung. Moreover, HSPA12B overexpression and DEX pre-treatment significantly reduces lung injury and inflammation levels by upregulating HSPA12B and inhibiting the activation of the TLR4/NF-κB signaling pathway. On the contrary, when the expression of HSPA12B is inhibited, the protective effect of DEX pre-treatment on lung tissue is significantly weakened.In summary, our research demonstrated that the increased expression of AAV-mediated HSPA12B in the lungs of mice inhibits acute inflammation and suppresses the activation of TLR4/NF-κB pathway in a murine model of LPS-induced ALI. DEX could enhance HSPA12B and inhibit the initiation and development of inflammation through down-regulating TLR4/NF-κB pathway.These findings highlight the potential of DEX as a therapeutic agent for treating ALI and ARDS, offering new strategies for clinical intervention.


Asunto(s)
Lesión Pulmonar Aguda , Dexmedetomidina , Proteínas HSP70 de Choque Térmico , Lipopolisacáridos , FN-kappa B , Transducción de Señal , Receptor Toll-Like 4 , Dexmedetomidina/farmacología , Dexmedetomidina/uso terapéutico , Lesión Pulmonar Aguda/inducido químicamente , Lesión Pulmonar Aguda/tratamiento farmacológico , Lesión Pulmonar Aguda/metabolismo , Lesión Pulmonar Aguda/patología , Lesión Pulmonar Aguda/prevención & control , Animales , Receptor Toll-Like 4/metabolismo , FN-kappa B/metabolismo , Transducción de Señal/efectos de los fármacos , Proteínas HSP70 de Choque Térmico/metabolismo , Ratones , Masculino , Ratones Endogámicos C57BL , Pulmón/patología , Pulmón/efectos de los fármacos , Pulmón/metabolismo , Interleucina-1beta/metabolismo
3.
Lab Chip ; 18(10): 1471-1484, 2018 05 15.
Artículo en Inglés | MEDLINE | ID: mdl-29666848

RESUMEN

Although microextraction is much more efficient than conventional macroextraction, its practical application has been limited by low throughputs and difficulties in constructing robust countercurrent microextraction (CCME) systems. In this work, a robust CCME process was established based on a novel passive microextractor with four units without any moving parts. The passive microextractor has internal recirculation and can efficiently mix two immiscible liquids. The hydraulic characteristics as well as the extraction and back-extraction performance of the passive CCME were investigated experimentally. The recovery efficiencies of the passive CCME were 1.43-1.68 times larger than the best values achieved using cocurrent extraction. Furthermore, the total throughput of the passive CCME developed in this work was about one to three orders of magnitude higher than that of other passive CCME systems reported in the literature. Therefore, a robust CCME process with high throughputs has been successfully constructed, which may promote the application of passive CCME in a wide variety of fields.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA